In a groundbreaking discovery, chronic pain has been shown to be physiologically different from acute pain and now scientists have the roadmap for how to target it.

The findings, published in Nature Genetics, offer critical insights into why some prostate cancers become resistant to therapy and how that shift could be blocked.